Gülkılık Gökhan, Karaman Erdur Sevil, Özbek Merve, Özsütçü Mustafa, Odabaşı Mahmut, Demirci Göktuğ, Kocabora Mehmet Selim, Eliaçık Mustafa
İstanbul Medipol University Faculty of Medicine, Department of Ophthalmology, İstanbul, Turkey.
Turk J Ophthalmol. 2016 Aug;46(4):161-164. doi: 10.4274/tjo.71601. Epub 2016 Aug 15.
To evaluate changes in anterior chamber depth (ACD) and postoperative refractive outcomes after combined phacovitrectomy.
This study included 10 eyes of 10 patients that underwent combined phacovitrectomy (study group) and 14 eyes of 14 patients that underwent phacoemulsification surgery (control group) at İstanbul Medipol University Ophthalmology Department. Preoperative and 3-month postoperative best corrected visual acuity (BCVA), ACD, change in ACD and refractive outcomes were compared between the two groups.
Preoperative ACD, postoperative ACD at 3 months and change in ACD were similar between two groups (p=0.403, p=0.886, p=0.841). Postoperative mean refractive outcomes were 0.22±0.51 diopter in the phacovitrectomy group and -0.39±0.53 diopter in the phacoemulsification group (p=0.019). BCVA was increased in both groups (p=0.001).
Postoperative refractive outcomes in eyes that underwent combined phacovitrectomy are different from those in eyes that underwent only phacoemulsification surgery. This is important in determining preoperative intraocular lens power before combined phacovitrectomy.
评估晶状体玻璃体联合切除术前后前房深度（ACD）的变化及术后屈光结果。
本研究纳入了在伊斯坦布尔梅迪波尔大学眼科接受晶状体玻璃体联合切除术的10例患者的10只眼（研究组），以及接受白内障超声乳化手术的14例患者的14只眼（对照组）。比较两组术前及术后3个月的最佳矫正视力（BCVA）、ACD、ACD变化及屈光结果。
两组术前ACD、术后3个月ACD及ACD变化相似（p = 0.403，p = 0.886，p = 0.841）。晶状体玻璃体联合切除组术后平均屈光结果为0.22±0.51屈光度，白内障超声乳化组为-0.39±0.53屈光度（p = 0.019）。两组BCVA均提高（p = 0.001）。
接受晶状体玻璃体联合切除术的患眼术后屈光结果与仅接受白内障超声乳化手术的患眼不同。这对于确定晶状体玻璃体联合切除术术前人工晶状体度数具有重要意义。
